X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (781) 781
Publication (64) 64
Book Review (10) 10
Patent (9) 9
Book Chapter (8) 8
Book / eBook (5) 5
Conference Proceeding (5) 5
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (401) 401
oncology (374) 374
index medicus (256) 256
melanoma (235) 235
male (230) 230
female (207) 207
middle aged (166) 166
cancer (162) 162
aged (144) 144
adult (133) 133
animals (124) 124
melanoma - pathology (111) 111
melanoma - drug therapy (109) 109
surgery (105) 105
immunology (87) 87
skin neoplasms - pathology (87) 87
isolated limb perfusion (79) 79
prognosis (78) 78
immunotherapy (76) 76
skin neoplasms - drug therapy (73) 73
aged, 80 and over (70) 70
treatment outcome (69) 69
melanoma - mortality (66) 66
neoplasm staging (66) 66
malignant-melanoma (65) 65
tumor necrosis factor-alpha - administration & dosage (65) 65
melphalan (64) 64
cutaneous melanoma (62) 62
melphalan - administration & dosage (62) 62
rats (62) 62
hematology, oncology and palliative medicine (60) 60
interferon-gamma (60) 60
metastatic melanoma (59) 59
survival (59) 59
review (58) 58
metastasis (56) 56
care and treatment (54) 54
antineoplastic agents - therapeutic use (52) 52
chemotherapy, cancer, regional perfusion (52) 52
disease-free survival (52) 52
medicine & public health (52) 52
tnf-alpha (51) 51
chemotherapy (50) 50
tumors (50) 50
melanoma - surgery (49) 49
sarcoma (49) 49
skin neoplasms - mortality (49) 49
melanoma - therapy (45) 45
tumor-necrosis-factor (45) 45
melanoma - secondary (44) 44
research (44) 44
therapy (44) 44
chemotherapy, cancer, regional perfusion - methods (43) 43
mice (42) 42
survival rate (42) 42
ipilimumab (40) 40
extremities (39) 39
adjuvant therapy (38) 38
lymphatic metastasis (38) 38
surgical oncology (38) 38
analysis (37) 37
health aspects (37) 37
antineoplastic agents - administration & dosage (36) 36
combined modality therapy (35) 35
survival analysis (35) 35
adolescent (34) 34
sarcoma - drug therapy (34) 34
skin neoplasms - surgery (34) 34
antineoplastic combined chemotherapy protocols - therapeutic use (33) 33
interferon (33) 33
clinical trials (32) 32
follow-up studies (31) 31
interferon-alpha - therapeutic use (31) 31
trial (31) 31
high-risk melanoma (30) 30
lymph node excision (30) 30
metastases (30) 30
retrospective studies (30) 30
time factors (30) 30
antineoplastic agents, alkylating - administration & dosage (29) 29
factor-alpha (29) 29
medicine, research & experimental (29) 29
chemotherapy, adjuvant (28) 28
combination (28) 28
sentinel lymph node biopsy (28) 28
pharmacology & pharmacy (27) 27
biopsy (26) 26
melanoma - immunology (26) 26
patients (26) 26
risk factors (26) 26
breast-cancer (25) 25
neoplasm metastasis (25) 25
prognostic-factors (25) 25
cell biology (24) 24
clinical trials as topic (24) 24
kaplan-meier estimate (24) 24
skin neoplasms - therapy (24) 24
young adult (24) 24
antibodies, monoclonal - therapeutic use (23) 23
expression (23) 23
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1993, Orientalia Lovaniensia analecta, ISBN 9789068314991, Volume 54, xv, 160
Book
1975, Orientalia Lovaniensia analecta, ISBN 9789061860372, Volume 3, xx, 233 p., [1] leaf of plates
Book
Molecular Oncology, ISSN 1574-7891, 2009, Volume 3, Issue 3, pp. 188 - 191
[...]Eggermont, as head of the department of Surgical Oncology at the Erasmus University Medical Centre, who also holds a Chair of Experimental Surgical... 
ONCOLOGY | Medical Oncology - methods | Neoplasms - therapy | Societies, Medical | Europe | Humans | Medical Oncology - trends | Initiatives | Medical research | Holidays & special occasions | Melanoma | Careers | Science | Oncology | Musicology | Publication output | Medicine | Chemotherapy | Tumor necrosis factor | Surgery | γ-Interferon | Melphalan | Cancer | Tumors | Views
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2018, Volume 378, Issue 19, pp. 1789 - 1801
A blinded trial involving patients with resected stage III melanoma showed that adjuvant pembrolizumab every 3 weeks for a year was associated with a 1-year... 
HIGH-RISK MELANOMA | SURVIVAL | MEDICINE, GENERAL & INTERNAL | ANTI-PD-1 THERAPY | EORTC 18952 | TUMOR BURDEN | CUTANEOUS MELANOMA | PHASE-3 TRIAL | PEGYLATED INTERFERON-ALPHA-2B | NODE-POSITIVE MELANOMA | IPILIMUMAB | Skin Neoplasms - drug therapy | Humans | Middle Aged | Male | Adjuvants, Immunologic - adverse effects | Skin Neoplasms - mortality | Aged, 80 and over | Adult | Female | Adjuvants, Immunologic - therapeutic use | Skin Neoplasms - surgery | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Kaplan-Meier Estimate | Neoplasm Recurrence, Local | Survival Rate | Disease-Free Survival | B7-H1 Antigen - antagonists & inhibitors | Melanoma - drug therapy | Intention to Treat Analysis | Quality of Life | Aged | B7-H1 Antigen - analysis | Infusions, Intravenous | Melanoma - surgery | Neoplasm Staging | Melanoma - mortality | Diagnosis | Drug therapy | Patients | Health aspects | Melanoma | Medical research | Lymphatic system | Risk groups | PD-1 protein | Committees | Metastasis | Survival | Skin cancer | Pembrolizumab | Hospitals | Motivation | PD-L1 protein | Myositis | Death | Mutation | Tumors | Cancer | Index Medicus | Abridged Index Medicus | Placebos | Placebos (Medicine) | Adjuvant treatment of cancer | Tractament adjuvant del càncer
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 5, pp. 522 - 530
Journal Article
by Gershenwald, Jeffrey E and Scolyer, Richard A and Hess, Kenneth R and Sondak, Vernon K and Long, Georgina V and Ross, Merrick I and Lazar, Alexander J and Faries, Mark B and Kirkwood, John M and McArthur, Grant A and Haydu, Lauren E and Eggermont, Alexander M. M and Flaherty, Keith T and Balch, Charles M and Thompson, John F and Gershenwald, Jeffrey E and Scolyer, Richard A and Atkins, Michael B and Balch, Charles M and Barnhill, Raymond L and Bilimoria, Karl Y and Buzaid, Antonio C and Byrd, David R and Cochran, Alistair J and Eggermont, Alexander M. M and Elder, David E and Faries, Mark B and Flaherty, Keith T and Garbe, Claus and Gardner, Julie M and Gimotty, Phyllis A and Halpern, Allan C and Haydu, Lauren E and Hess, Kenneth R and Johnson, Timothy M and Kirkwood, John M and Lazar, Alexander J and Lee, Anne W. M and Long, Georgina V and McArthur, Grant A and Mihm Jr, Martin C and Prieto, Victor G and Ross, Merrick I and Sober, Arthur J and Sondak, Vernon K and Thompson, John F and Wong, Sandra L and Delman, Keith A and Santinami, Mario and Maurichi, Andrea and Nagore, Eduardo and Faries, Mark B and Thompson, John F and Scolyer, Richard A and McArthur, Grant A and Gyorki, David E and Henderson, Michael and Stratigos, Alexander J and Gogas, Helen and Gershenwald, Jeffrey E and Haydu, Lauren E and Rossi, Carlo Riccardo and Sommariva, Antonio and American Joint Comm Canc Melanoma and Int Melanoma Database Discovery and for members of the American Joint Committee on Cancer Melanoma Expert Panel and the International Melanoma Database and Discovery Platform
CA: A Cancer Journal for Clinicians, ISSN 0007-9235, 11/2017, Volume 67, Issue 6, pp. 472 - 492
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 12/2010, Volume 17, Issue 12, pp. 3314 - 3323
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2016, Volume 375, Issue 19, pp. 1845 - 1855
Journal Article